HIV Flashcards

1
Q

What type of virus is HIV?

A

Enveloped, diploid, single-stranded, positive-sense RNA viruses with a DNA intermediate (which is an integrated viral genome (a provirus) that persists within the host-cell DNA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How does HIV produce cellular immune deficiency?

A
  • Characterized by the depletion of helper T lymphocytes (CD4+ cells)
  • The loss of CD4+ cells results in the development of opportunistic infections and neoplastic processes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

By the #s - global estimates for adults and children, 2008 vs. 2016

A
  • People living with HIV – 33.4 million vs 36.7 million
  • New HIV infections 2.7 million vs 1.8 million
  • Deaths due to AIDS 2.0 million vs 1.0 million
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which age bracket contains the largest % of HIV cases?

A

20-29 y/o make up 37% of HIV cases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which modes of transmission have the highest % likelihood?

A
  • Mother-infant 15-35% (*~2%)

- Transfusion 80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Who should get tested for HIV?

A
  • All patients aged 13-64 in all health-care settings*
  • HIV screening should be voluntary
  • Opt-out screening: patients are notified that testing will be performed unless they decline
  • Separate written consent for HIV testing not recommended; general informed consent is sufficient
  • Prevention counseling should not be required
  • High-risk patients should be screened at least annually
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Who is at highest risk for HIV?

A
  • Unprotected sexual intercourse, especially receptive anal intercourse (8-fold higher risk of transmission)
  • A large number of sexual partners
  • **Prior or current sexually transmitted diseases (STDs):
  • Sharing of intravenous drug paraphernalia
  • Receipt of blood products (before 1985 in the United States)
  • Mucosal contact with infected blood or needle-stick injuries
  • Maternal HIV infection (for newborns, infants, and children)
  • Gay and bisexual men (including transgender), particularly young African American, are most affected
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which STDs increase risk for HIV?

A

Gonorrhea and chlamydia infections increase the HIV transmission risk 3-fold, syphilis raises the transmission risk 7-fold, and herpes genitalis raises the transmission risk up to 25-fold during an outbreak

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

List the ways to reduce HIV risk

A
  • Consistent, correct condom use
  • Screening and tx of STIs in individuals at risk for HIV
  • Addiction tx for IV drug users and/or participation in needle exchange programs
  • In those with high ongoing risk for infection daily pre-exposure prophylaxis with tenofovir-emtricitabine (Truvada)
  • If mucosal or parenteral exposure to HIV within the prior 72 hours, post exposure prophylaxis with ART
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which patients should have HIV screening at least annually?

A
  • Injection-drug users (IDUs)
  • Sex partners of IDUs
  • Persons who exchange sex for money or drugs
  • Sex partners of HIV infected
  • Men who have sex with men (MSM)
  • Heterosexuals who themselves or their sex partners have had >1 sex partner since last HIV test
  • Before new sexual relationship
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Diagnosis of HIV

-acute or early infection

A

Combination antigen/antibody immunoassay and HIV viral load (RT-PCR based)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Diagnosis of HIV

-immunoassay/VL results

A

(-) immunoassay and (-) VL signifies no HIV infection (if recent exposure repeat in 1-2 weeks)

(-) immunoassay and (+) VL suggests an early infection (VL <1000 copies/ml very rarely represents false positive test, repeat!)

(+) immunoassay and (+) VL, early or established infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the next step in the event of (+) immunoassay?

A

(+) immunoassay needs a second, antibody-only immunoassay (preferably the HIV-1/HIV-2 differentiation immunoassay) if not already performed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the 3 phases of HIV/AIDS?

A
  1. Primary HIV infection
  2. Chronic asymptomatic phase
  3. Advanced AIDS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Etiology of primary HIV infection

A
  • Symptomatic illness in 40-90%
  • Illness is nonspecific and mononucleosis-like
  • Appears 2-4 weeks after exposure
  • Clinical illness lasts 1-4 weeks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

List the acute retroviral syndrome symptoms

A
  • Fever
  • Lymphadenopathy
  • Pharyngitis
  • Rash
  • Myalgias
  • GI complaints
  • Encephalopathy

*Ask your patient if at any point since their last HIV (-) test they’ve experienced these symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe the rash seen with primary HIV

A
  • Maculopapular rash affecting face, neck, and trunk
  • Usually individual lesions < 1cm
  • Confluence rare
18
Q

What lab values will you see with primary HIV?

A
  • Thrombocytopenia
  • Leukopenia
  • WBCs drop
  • Elevated ALT, AST
  • Elevated ESR
  • ELISA often negative (window period)
19
Q

Define the chronic asymptomatic phase

A

Characterized by a long phase of clinical latency (median 10 yrs)

20
Q

What is happening with viral replication in chronic asymptomatic phase? Where is the virus replicating?

A
  • Viral replication and CD4+ counts are relatively stable

- Virus is actively replicating in lymphoid tissue causing anatomic and functional deterioration

21
Q

When should we consider our patient to be in category of chronic asymptomatic phase?

A

If our patient has no signs/symptoms of OIs (opportunistic infections) and last HIV test was 7 years ago she might be in this category

22
Q

Etiology of advanced AIDS

A
  • Defines the end stage of HIV infection
  • Leads to death in 2-3 years in the absence of therapy (opportunistic infections)
  • Characterized by high plasma viral load and low CD4+ count
23
Q

List common opportunistic infections

A
  • PCP pneumonia
  • CMV
  • Disseminated/ extrapulmonary MAC
  • Wasting syndrome
  • Invasive cervical cancer
  • Kaposi’s sarcoma
24
Q

What can you tell your patient about her life expectancy?

A
  • HIV is no longer a ‘death sentence’
  • Diabetes mellitus can be a useful analogy
  • Chronic, incurable disease
  • Requires daily medications
25
What lab test will you order?
- CD4 T-cell count - HIV RNA/viral load - CBC with differential - CMP - TB - Drug resistance *variety of others, review slide
26
What does CD4 count of 500-1,500 mean?
Normal range, usually symptom-free
27
What does CD4 count of < 500 mean?
Increased risk for HIV-related minor phenomena, e.g. seborrheic dermatitis, generalized lymphadenopathy, periodontal disease
28
What does CD4 count of < 300-350 mean?
Increased risk for recurrent bacterial pneumonia, TB, lymphoma, Kaposi’s sarcoma, oral candidiasis, zoster
29
What does CD4 count of < 200 mean?
increased risk for major opportunistic infections: PCP, esophageal candidiasis, chronic mucocutaneous HSV, cryptosporidiosis
30
What prophylaxis can you give with CD4 count < 200?
Bactrim DS 1 tab PO daily for PCP prophylaxis
31
What does CD4 count of < 50-100 mean?
Profound increased risk for all opportunistic processes
32
What are the new recommendations for starting ART?
Initiate ART soon after initial diagnosis in nearly all HIV-infected patients, regardless of the CD4 count
33
What should you consider in patients needing to start ART?
Some patients may have barriers to taking daily therapy because of concurrent conditions (e.g., active depression, substance use) or social instability (e.g., homelessness)
34
What CD4 counts go into considerations with patients with barriers?
- CD 4 > 350 cells/microL (especially > 500 cells/micoL) and no HIV-related symptoms or complications we may choose to delay therapy - Once CD4 < 350 cells/micoL we initiate ART regardless of these barriers
35
What are the goals of HIV treatment?
- Reduce HIV-related morbidity and mortality - Restore and/or preserve immunologic function - Maximally and durably suppress HIV viral load - Prevent HIV transmission
36
What are potential barriers to adherence to HIV treatment?
- Ongoing substance abuse - Pill burden - Inconvenient dosing schedule - Dietary restrictions - Denial
37
List the predictors of poor adherence
- Active alcohol or substance abuse - Work outside the home for pay - Depressed mood - Lack of perceived efficacy of ART - Lack of advanced disease - Concern over side effects - Regimen complexity
38
Health care maintenance - what vaccines should HIV patients have?
- Hepatitis A, hepatitis B (if not immune) - Pneumococcal - Influenza - Tetanus
39
What is the recommendation for pap smears in HIV patients?
-Every 6 months initially, then yearly if negative* **Not less than once per year!! 0If comes back as ASCUS cells or more significant abnormality, get colposcopy per latest guidelines (do not triage by HPV status)
40
Health care maintenance - breast, prostate, colorectal cancer screening
Same as for HIV-negative patients
41
Health care maintenance - cholesterol screening
- Protease inhibitors, efavirenz, some NRTIs associated with dyslipidemia - Check baseline lipids before treatment and periodically after initiation of treatment - Higher rates of CAD among HIV-infected patients
42
What referrals apply to patients in Oklahoma?
- Ryan White Care Act Part B: Grantee is the Oklahoma State Department of Health. - Services provided are case management, dental, mental health/substance abuse, transportation, lab, HIV testing and counseling, medicines, & HDAP